Everolimus Tablets 10 mg

Product Description

Everolimus, a mTOR inhibitor used to treat a variety of cancers and non-cancerous disorders, is the active component of Everolimus Tablets 10 mg. Everolimus functions by inhibiting mTOR, a protein that controls cell division and proliferation. It is recommended for advanced kidney cancer, breast cancer, pancreatic neuroendocrine tumours, and several types of brain tumours. The dosage of the oral pills is determined by the patients health status and reaction to treatment. The most typical adverse reactions include weariness, diarrhoea, dermatitis, and mouth sores. Everolimus 10 mg has shown effective in treating certain problems, offering potential advantages and better outcomes for those who are dealing with them. During treatment, close medical care is required.

Everolimus 10 mg Tablets Features:

1. Everolimus, a mTOR inhibitor well-known for its efficacy in treating cancer and non-cancerous conditions, is the active ingredient in the pills.

2. Everolimus works by inhibiting mTOR, a protein that controls cell growth and division, which stops the formation of cancer cells while also treating some non-cancerous illnesses.

3. For the treatment of advanced kidney cancer, pancreatic neuroendocrine tumours, breast cancer, and specific types of brain tumours, Everolimus Tablets 10 mg are suggested.

4. The tablets are administered orally, offering a practical and non-intrusive means of drug delivery.

5. Offering a personalised therapeutic strategy, the dosage of Everolimus is provided based on each patients unique medical condition and reaction to therapy.

Benefits of 10 mg Everolimus Tablets:

1. Everolimus has shown effectiveness in the treatment of advanced kidney cancer, pancreatic neuroendocrine tumours, breast cancer, and certain types of brain tumours, potentially providing benefits and better outcomes for people with these particular cancers.

2. Everolimus prevents cancer cells from growing and dividing by blocking mTOR, which helps to slow or stop the formation of tumours.

3. Long-Term Disease regulate: Everolimus medication can help patients with these advanced malignancies regulate their condition and live better.

4. Treatment for Non-Cancerous disorders: Everolimus is also used to control tumour growth and lessen symptom load in some non-cancerous disorders, such as Tuberous Sclerosis Complex and Subependymal Giant Cell Astrocytoma.

5. Adjunct to Other Therapies: To improve overall cancer care, everolimus may be used in conjunction with other cancer therapies or drugs.

6. Oral Treatment Option: Everolimus is administered orally, which is more convenient for patients and enables outpatient or at-home care.

7. Everolimus 10 mg Tablets are generally well tolerated, with side effects that are commonly tolerable and exceeded by the therapeutic advantages.

8. Potential for enhanced Survival: Patients with advanced kidney cancer, pancreatic neuroendocrine tumours, and specific brain tumours may experience enhanced survival after receiving everolimus treatment.

Individual responses to Everolimus Tablets 10 mg may differ, thus close medical supervision and monitoring are necessary to address any potential side effects and improve therapy results.Throughout the course of treatment, patients should speak with their medical specialists for personalised counsel and direction.

How does it work?

This medication includes the active ingredient everolimus, which is a protein kinase inhibitor. Evertor works by inhibiting with the pathways signaling specific cancer cells to increase. Everolimus attaches with definite protein inside the cancer cells, and thus block the activity of protein kinase known as mammalian target of rapamycin (mTOR). This stops the growth and multiply of cancer cells. Also, it stops the growth of blood vessels into tumor. Both the effects stop the growth of tumor.

Uses:

This medication is effective in the treatment of cancers like breast cancer, kidney cancer, and neuroendocrine tumor. Also, it may be used for other conditions:

• Advanced renal cell cancer treatment and pancreatic neuroendocrine tumors.
• Treatment of HER2-negative breast cancer, advanced hormone receptor positive, etc.
• Treatment of neuroendocrine tumors (NET) of gastrointestinal (GI), in certain forms.

How do I take it?

It should be taken once in a day, at same time. Can be taken with or without food. Swallow the entire tablet with a glass of water, do not break, chew or crush. Do not overdose.

Side Effects:

Some common side effects are following:

• Enhanced blood cholesterol level
• Low red blood cell count
• Mouth sores
• Low phosphorus level
• Infection and Weakness
• Diarrhea and Cough etc.

Some less common side effects:

• Rash
• Increased liver enzymes
• Low blood counts
• Nausea or vomiting
• Swelling
• Shortness of breath
• Poor appetite
• Fever and Fatigue
• Nosebleeds
• Itching
• Lung problems

Advanced Oral Therapy for Cancer

Everolimus Tablets 10 mg offer a modern approach to managing several forms of cancer. As an mTOR inhibitor, Everolimus works by disrupting cancer cell growth and proliferation. Its oral tablet form simplifies dosing and supports patient compliance, making it a preferred option for oncologists and healthcare providers alike.


Stringently Sourced and Supplied Globally

Sourced and manufactured in India, Everolimus Tablets are distributed worldwide by trusted exporters, suppliers, traders, and wholesalers. Each product batch undergoes rigorous quality control, ensuring consistent potency and safety for international customers seeking effective cancer treatment options.


Reliable Shelf Life and Storage Efficiency

These tablets provide a reliable 1-year shelf life when stored at recommended room temperature. The products normal fermentation smell ensures authenticity and stability, aiding users and healthcare providers in quality assurance and handling processes.